Think Research Corporation

Equities

THNK

CA88410J1075

Software

Market Closed - Toronto S.E. 03:56:16 2024-03-28 pm EDT 5-day change 1st Jan Change
0.31 CAD +1.64% Intraday chart for Think Research Corporation 0.00% +63.16%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Think Research Says No Alternative Buyers Emerge as Shareholder Vote Next Week on Going Private Transaction MT
Think Research Brief: Co Says "Now subject to a non-solicitation covenant with customary "fiduciary out" provisions Under Terms of the Arrangement Agreement MT
Think Research Brief: Providing Update on Going Private Transaction; "Go-shop" Period Expired on March 16, 2024, With No Acquisition Proposal Having Been Received MT
Think Research Corp. Provided a Financial Update MT
Think Research Announces $5.0 Million Contract Expansion with a Global Pharmaceutical Company CI
Think Research Agrees to be Bought by Beedie Capital; Up 87.5% MT
Think Research Agrees to be Bought by Beedie Capital MT
Think Research Brief: Shareholders to receive cash payment of $0.32 per Common Share MT
Think Research Brief: Entering into Definitive Agreement to be Acquired by Beedie Capital MT
Beedie Capital entered into an arrangement agreement to acquire remaining stake in Think Research Corporation (TSXV : THNK) from shareholders. CI
Think Research Secures $1 Million Subsequent Advance Under Existing Convertible Facility; Up 7% MT
Think Research Secures $1 Million Subsequent Advance Under Existing Convertible Facility MT
Think Research's Learning Management System to Support Healthcare Professional Education and Training CI
Transcript : Think Research Corporation, Q3 2023 Earnings Call, Nov 27, 2023
Think Research Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Think Research Corporation Appoints Jeffrey Orridge to Its Board of Directors CI
Major Long-Term Care Pharmacy Selects Think Research Corporation's Pharmapod to Enhance Medication Safety CI
Think Research Announces Agreement For Advance Under Convertible Facility MT
Think Research Corporation Announces Technology Partner Supporting Ontario Ministry of Health's One Stop Talk/Parlons Maintenant Service for Child and Youth Mental Health CI
Think Research Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Think Research Corporation, Q2 2023 Earnings Call, Aug 29, 2023
Think Research Corporation Announces Bridge Loan CI
Think Research Detailed Bridge Loan MT
Transcript : Think Research Corporation - Shareholder/Analyst Call
Think Research's Pharmapod Selected by Neighbourly Pharmacy to Manage Medication Safety for Nearly 300 Locations MT
Chart Think Research Corporation
More charts
Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.31 CAD
Average target price
0.5 CAD
Spread / Average Target
+61.29%
Consensus